Neuroscience research has dramatically advanced our understanding of psychedelics's mechanisms, informing better treatments and reducing stigma.
Key Brain Structures in Psychedelics
Modern neuroimaging has identified consistent patterns in psychedelics:
- Amygdala: Threat processing center shows altered activation patterns in psychedelics
- Prefrontal Cortex: Top-down emotional regulation — often underactive in psychedelics
- Anterior Cingulate Cortex: Conflict monitoring and pain processing — implicated in psychedelics
- Hippocampus: Memory and context; chronic stress in psychedelics can affect its volume
- Default Mode Network: Rumination and self-referential thinking network — often overactive in psychedelics
Neurochemistry of Psychedelics
While the 'chemical imbalance' model is oversimplified, neurotransmitter systems play real roles in psychedelics:
- Serotonin regulates mood, appetite, and sleep — all affected in psychedelics
- Dopamine drives motivation and reward — disrupted in many psychedelics presentations
- GABA and glutamate modulate excitation/inhibition balance relevant to psychedelics
What Neuroscience Means for Psychedelics Treatment
Neuroscience validates that psychedelics is a brain condition, not a character failing. It points toward treatments that target specific mechanisms — and shows that both therapy and medication physically change the brain.